EpiVax Oncology epivaxonco.com


EpiVax Oncology (EO) is developing precision cancer immunotherapies based on Neo-Epitopes selected using proprietary and validated, in silico, predictive algorithms. Using genetic profiling (via NGS Sequencing), EO's therapeutic vaccines are customized and specifically designed for each patient's tumors.

EpiVax Oncology (EO) is developing precision cancer immunotherapies based on Neo-Epitopes selected using proprietary and validated, in silico, predictive algorithms. Using genetic profiling (via NGS Sequencing), EO's therapeutic vaccines are customiz...Show all

Company (Alive / Active)

Phone: 401-272-2123

Fax:

146 Clifford Street

Providence, 02903
Rhode Island, United States

Latest News

See more competitors data Competitors
Total Funding Date of Last Funding
EpiVax Oncology $0.6M Dec 11, 2017

Web Traffic

Rank

Show (-10)

Engagement (PVPU)

Show (+1%)

Domain Authority Score
Show
Page Views Per Million (PVPM)
Show
Reach Per Million
Show

SEO Statistics

Domain Authority Score Show
Page Authority Score Show
No. External Links Show
No. Links Show

Web Traffic Statistics - Growth

Per Week Per Month Per 6 Months Per Year
Rank Login to see details
Page Views Per Million Login to see details
Page Views Per User Login to see details
Reach Per Million Login to see details

Related EpiVax Oncology Jobs

jobs by Indeed job
						search

Investors

Investor Investor Type Location Participating Rounds
See all 1 investors
There is no Board of Directors data available for this company. Please select another tab.
There is no Competitors data available for this company. Please select another tab.

Patents

Title Application Date Patent Date Status
(Patent / Application)